Tapewire

Nasdaq · USD

AQST

Aquestive Therapeutics, Inc.

Export transactions ↓
Tapewire entity
5276
SEC CIK
0001398733
Parsed reports
319

Last 12 months

Inside the activity.

0 purchase rows · 15 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202607
Apr 202600
May 202601
Jun 202602
Jul 202602
Aug 202601
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 09, 2026 Filed Mar 11, 2026 16:52 UTC
Boyd Peter E.Chief People Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 42,500 $4.29 Strike: $4.29 $182,325.00
Disclosure

SEC source: 0001214659-26-003147 · marketforms-72463.xml · derivative · entry 3

Boyd Peter E. · CIK 0001739816 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,500

Underlying: Common Stock · 42,500 shares

Expires 2036-03-09

F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:52 UTC
Boyd Peter E.Chief People Officer
GrantCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-003147 · marketforms-72463.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,323

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:50 UTC
Jung CassieChief Operating Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 42,500 $0.00 Strike: $4.29 $0.00
Disclosure

SEC source: 0001214659-26-003141 · marketforms-72467.xml · derivative · entry 4

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,500

Underlying: Common Stock · 42,500 shares

Expires 2036-03-09

F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:50 UTC
Jung CassieChief Operating Officer
GrantCommon Stock 80,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-003141 · marketforms-72467.xml · nonDerivative · entry 2

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,771

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:52 UTC
Cioffi MelinaSVP, Regulatory Affairs
GrantNon-Qualified Stock Option (right to buy) · Derivative 75,000 $4.29 Strike: $4.29 $321,750.00
Disclosure

SEC source: 0001214659-26-003144 · marketforms-72465.xml · derivative · entry 3

Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

Underlying: Common Stock · 75,000 shares

Expires 2036-03-09

F4 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:52 UTC
Cioffi MelinaSVP, Regulatory Affairs
GrantCommon Stock 100,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-003144 · marketforms-72465.xml · nonDerivative · entry 1

Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,178

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:49 UTC
Davis Matthew W.Chief Development Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $4.29 $0.00
Disclosure

SEC source: 0001214659-26-003140 · marketforms-72466.xml · derivative · entry 2

Davis Matthew W. · CIK 0002094283 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-03-09

F2 · derivative.exercise_date: The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 16:49 UTC
Davis Matthew W.Chief Development Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-003140 · marketforms-72466.xml · nonDerivative · entry 1

Davis Matthew W. · CIK 0002094283 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 13:25 UTC
Greenhawt Matthew J.Chief Medical Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 50,000 $4.29 Strike: $4.29 $214,500.00
Disclosure

SEC source: 0001214659-26-003134 · marketforms-72376.xml · derivative · entry 3

Greenhawt Matthew J. · CIK 0002113518 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2036-03-09

F2 · derivative.exercise_date: The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 09, 2026 Filed Mar 11, 2026 13:25 UTC
Greenhawt Matthew J.Chief Medical Officer
GrantCommon Stock 75,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-26-003134 · marketforms-72376.xml · nonDerivative · entry 2

Greenhawt Matthew J. · CIK 0002113518 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 75,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
December 04, 2025 Filed Dec 5, 2025 18:06 UTC
Boyd Peter E.Chief People Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-017652 · marketforms-71415.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · Chief People Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 288,323

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
December 02, 2025 Filed Dec 4, 2025 15:39 UTC
Cioffi MelinaSVP, Regulatory Affairs
Tax withholdingCommon Stock 2,083 $5.93 $12,352.19
Disclosure

SEC source: 0001214659-25-017591 · marketforms-71360.xml · nonDerivative · entry 1

Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,178

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 14:35 UTC
Davis Matthew W.Chief Development Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 50,000 $0.00 Strike: $5.58 $0.00
Disclosure

SEC source: 0001214659-25-016275 · marketforms-71182.xml · derivative · entry 2

Davis Matthew W. · CIK 0002094283 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires 2035-11-10

F2 · derivative.exercise_date: The option will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
November 10, 2025 Filed Nov 12, 2025 14:35 UTC
Davis Matthew W.Chief Development Officer
GrantCommon Stock 50,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-016275 · marketforms-71182.xml · nonDerivative · entry 1

Davis Matthew W. · CIK 0002094283 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:01 UTC
Jung CassieChief Operating Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.10 $0.00
Disclosure

SEC source: 0001214659-25-015048 · marketforms-71051.xml · derivative · entry 4

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2031-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F3 · derivative.exercise_date: This option was granted on June 10, 2021 and is fully vested.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:01 UTC
Jung CassieChief Operating Officer
SaleCommon Stock 67,575 $7.01 $473,700.75
Disclosure

SEC source: 0001214659-25-015048 · marketforms-71051.xml · nonDerivative · entry 3

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 240,771

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:01 UTC
Jung CassieChief Operating Officer
Exercise / conversionCommon Stock 25,000 $3.10 $77,567.50
Disclosure

SEC source: 0001214659-25-015048 · marketforms-71051.xml · nonDerivative · entry 2

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 308,346

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:01 UTC
Kraus Carl NChief Medical Officer
SaleCommon Stock 20,272 $7.00 $141,904.00
Disclosure

SEC source: 0001214659-25-015047 · marketforms-71050.xml · nonDerivative · entry 1

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 282,475

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

F2 · price: The reported transaction involves sale transactions from $7.00 to $7.02 per share. The weighted average price per share was $7.00. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

Read SEC document
October 15, 2025 Filed Oct 17, 2025 18:00 UTC
Boyd Peter E.See Remarks
SaleCommon Stock 10,000 $7.00 $70,000.00
Disclosure

SEC source: 0001214659-25-015046 · marketforms-71047.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 268,323

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Read SEC document
September 26, 2025 Filed Sep 29, 2025 20:26 UTC
Barber DanielDirector · President and CEO
SaleCommon Stock 91,343 $6.03 $551,191.06
Disclosure

SEC source: 0001214659-25-014288 · marketforms-70872.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 923,430

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

F2 · price: The reported transaction involves sale transactions from $6.00 to $6.11 per share. The weighted average price per share was $6.0343. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price.

Read SEC document
September 26, 2025 Filed Sep 29, 2025 20:26 UTC
Boyd Peter E.See Remarks
SaleCommon Stock 10,000 $6.30 $63,000.00
Disclosure

SEC source: 0001214659-25-014287 · marketforms-70873.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 278,323

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Read SEC document
September 19, 2025 Filed Sep 22, 2025 21:25 UTC
Barber DanielDirector · President and CEO
SaleCommon Stock 400 $6.00 $2,400.00
Disclosure

SEC source: 0001214659-25-014009 · marketforms-70823.xml · nonDerivative · entry 1

Barber Daniel · CIK 0001742266 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,014,773

F1 · shares: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Read SEC document
September 05, 2025 Filed Sep 8, 2025 21:13 UTC
Boyd Peter E.See Remarks
SaleCommon Stock 15,000 $5.30 $79,500.00
Disclosure

SEC source: 0001214659-25-013485 · marketforms-70566.xml · nonDerivative · entry 1

Boyd Peter E. · CIK 0001739816 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 288,323

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 23:06 UTC
Jung CassieChief Operating Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $0.71 $0.00
Disclosure

SEC source: 0001214659-25-013493 · marketforms-70687.xml · derivative · entry 6

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2032-08-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F4 · derivative.exercise_date: This option was granted on August 5, 2022 and is fully vested.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 23:06 UTC
Jung CassieChief Operating Officer
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative 25,000 $0.00 Strike: $3.15 $0.00
Disclosure

SEC source: 0001214659-25-013493 · marketforms-70687.xml · derivative · entry 5

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 25,000 shares

Expires 2029-08-09

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

F3 · derivative.exercise_date: This option was granted on August 9, 2019 and is fully vested.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 23:06 UTC
Jung CassieChief Operating Officer
SaleCommon Stock 62,180 $5.00 $310,900.00
Disclosure

SEC source: 0001214659-25-013493 · marketforms-70687.xml · nonDerivative · entry 4

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 283,346

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 23:06 UTC
Jung CassieChief Operating Officer
Exercise / conversionCommon Stock 25,000 $0.71 $17,657.50
Disclosure

SEC source: 0001214659-25-013493 · marketforms-70687.xml · nonDerivative · entry 3

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 345,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Read SEC document
September 04, 2025 Filed Sep 8, 2025 23:06 UTC
Jung CassieChief Operating Officer
Exercise / conversionCommon Stock 25,000 $3.15 $78,750.00
Disclosure

SEC source: 0001214659-25-013493 · marketforms-70687.xml · nonDerivative · entry 2

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 320,526

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This is a scheduled exercise from 10b5-1 trading plan. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was affected.

Read SEC document
August 14, 2025 Filed Aug 15, 2025 12:41 UTC
Korczynski SherryChief Commercial Officer
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-012304 · marketforms-70071.xml · nonDerivative · entry 1

Korczynski Sherry · CIK 0002026090 · Chief Commercial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,858

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
August 09, 2025 Filed Aug 12, 2025 14:11 UTC
Kraus Carl NChief Medical Officer
Tax withholdingCommon Stock 10,819 $3.90 $42,194.10
Disclosure

SEC source: 0001214659-25-011823 · marketforms-70221.xml · nonDerivative · entry 1

Kraus Carl N · CIK 0001946475 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,747

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 17:59 UTC
Krop JulieDirector
GrantStock Option (Right to Purchase) · Derivative 42,000 $3.41 Strike: $3.41 $143,220.00
Disclosure

SEC source: 0001214659-25-009123 · marketforms-69482.xml · derivative · entry 1

Krop Julie · CIK 0001643127 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Krop's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 13:57 UTC GrantStock Option (Right to Purchase) · Derivative 42,000 $3.41 Strike: $3.41 $143,220.00
Disclosure

SEC source: 0001214659-25-009118 · marketforms-69475.xml · derivative · entry 1

Taglietti Marco · CIK 0001408870 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Taglietti's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 17:58 UTC
Cochran JohnDirector
GrantStock Option (Right to Purchase) · Derivative 42,000 $3.41 Strike: $3.41 $143,220.00
Disclosure

SEC source: 0001214659-25-009120 · marketforms-69480.xml · derivative · entry 2

Cochran John · CIK 0001406773 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Mr. Cochran's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 13:59 UTC GrantStock Option (right to purchase) · Derivative 42,000 $3.41 Strike: $3.41 $143,220.00
Disclosure

SEC source: 0001214659-25-009122 · marketforms-69483.xml · derivative · entry 1

MORRIS TIMOTHY E · CIK 0001191286 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Mr. Morris' continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 14:13 UTC GrantStock Option (Right to Purchase) · Derivative 42,000 $3.41 Strike: $3.41 $143,220.00
Disclosure

SEC source: 0001214659-25-009128 · marketforms-69477.xml · derivative · entry 2

BROWN GREGORY B · CIK 0001373585 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 11, 2025 Filed Jun 12, 2025 17:59 UTC GrantNon-Qualified Stock Option (right to buy) · Derivative 42,000 $3.41 Strike: $3.41 $143,220.00
Disclosure

SEC source: 0001214659-25-009121 · marketforms-69481.xml · derivative · entry 1

Jenkins Abigail L. · CIK 0001947032 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-06-11

F1 · derivative.exercise_date: The shares underlying the options vest as follows: 100% of the underlying shares vest June 11, 2026, subject to Ms. Jenkins' continuous service with the Issuer from the grant date through the applicable vesting date.

Read SEC document
June 09, 2025 Filed Jun 10, 2025 18:12 UTC
Korczynski SherrySVP Sales and Marketing
Tax withholdingCommon Stock 2,714 $3.54 $9,607.56
Disclosure

SEC source: 0001214659-25-009047 · marketforms-69905.xml · nonDerivative · entry 1

Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 156,858

F1 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
May 15, 2025 Filed May 15, 2025 16:59 UTC
Cioffi MelinaSVP, Regulatory Affairs
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-007749 · marketforms-69454.xml · nonDerivative · entry 1

Cioffi Melina · CIK 0002066841 · SVP, Regulatory Affairs

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 202,261

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 21:49 UTC
Wargacki StephenChief Science Officer
Tax withholdingCommon Stock 4,572 $2.54 $11,612.88
Disclosure

SEC source: 0001214659-25-004228 · marketforms-68577.xml · nonDerivative · entry 4

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 343,552

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 10, 2025 Filed Mar 11, 2025 21:48 UTC
Jung CassieChief Operating Officer
Tax withholdingCommon Stock 2,182 $2.54 $5,542.28
Disclosure

SEC source: 0001214659-25-004227 · marketforms-68571.xml · nonDerivative · entry 5

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 295,526

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 21:48 UTC
TOTH A ERNEST JRChief Financial Officer
Tax withholdingCommon Stock 8,736 $2.65 $23,150.40
Disclosure

SEC source: 0001214659-25-004226 · marketforms-68575.xml · nonDerivative · entry 3

TOTH A ERNEST JR · CIK 0001280273 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 339,366

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 21:49 UTC
Wargacki StephenChief Science Officer
Tax withholdingCommon Stock 15,431 $2.65 $40,892.15
Disclosure

SEC source: 0001214659-25-004228 · marketforms-68577.xml · nonDerivative · entry 3

Wargacki Stephen · CIK 0001960165 · Chief Science Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 348,124

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 21:48 UTC
Jung CassieChief Operating Officer
Tax withholdingCommon Stock 7,997 $2.65 $21,192.05
Disclosure

SEC source: 0001214659-25-004227 · marketforms-68571.xml · nonDerivative · entry 4

Jung Cassie · CIK 0001960154 · Chief Operating Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 297,708

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 21:47 UTC
BRAENDER LORI JChief Legal Officer
Tax withholdingCommon Stock 10,658 $2.65 $28,243.70
Disclosure

SEC source: 0001214659-25-004223 · marketforms-68569.xml · nonDerivative · entry 3

BRAENDER LORI J · CIK 0001752955 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 402,981

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 21:47 UTC
Boyd Peter E.See Remark
Tax withholdingCommon Stock 7,681 $2.65 $20,354.65
Disclosure

SEC source: 0001214659-25-004222 · marketforms-68504.xml · nonDerivative · entry 3

Boyd Peter E. · CIK 0001739816 · See Remark

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 303,323

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 09, 2025 Filed Mar 11, 2025 21:47 UTC
Barber DanielPresident and CEO
Tax withholdingCommon Stock 53,998 $2.65 $143,094.70
Disclosure

SEC source: 0001214659-25-004221 · marketforms-68502.xml · nonDerivative · entry 3

Barber Daniel · CIK 0001742266 · President and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,015,173

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:48 UTC
Korczynski SherrySVP Sales and Marketing
GrantNon-Qualified Stock Option (right to buy) · Derivative 35,000 $0.00 Strike: $2.65 $0.00
Disclosure

SEC source: 0001214659-25-004224 · marketforms-68572.xml · derivative · entry 3

Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 35,000

Underlying: Common Stock · 35,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:48 UTC
Korczynski SherrySVP Sales and Marketing
Tax withholdingCommon Stock 5,428 $2.65 $14,384.20
Disclosure

SEC source: 0001214659-25-004224 · marketforms-68572.xml · nonDerivative · entry 2

Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 159,572

F2 · shares: Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:48 UTC
Korczynski SherrySVP Sales and Marketing
GrantCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001214659-25-004224 · marketforms-68572.xml · nonDerivative · entry 1

Korczynski Sherry · CIK 0002026090 · SVP Sales and Marketing

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,000

F1 · shares: The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 21:48 UTC
TOTH A ERNEST JRChief Financial Officer
GrantNon-Qualified Stock Option (right to buy) · Derivative 60,000 $0.00 Strike: $2.65 $0.00
Disclosure

SEC source: 0001214659-25-004226 · marketforms-68575.xml · derivative · entry 4

TOTH A ERNEST JR · CIK 0001280273 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2035-03-07

F3 · derivative.exercise_date: The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.